3'-Phosphoadenosine-5'-phosphosulfate

3'-Phosphoadenosine-5'-phosphosulfate (PAPS) is a crucial sulfate donor molecule involved in the process of sulfation, which is essential for the biosynthesis of important sulfated glycosaminoglycans, sulfated lipids, and sulfated proteins. This compound plays a pivotal role in various biological processes, including detoxification, hormone regulation, and molecular signaling. PAPS is considered the universal sulfate donor in all living organisms, highlighting its fundamental importance in biochemistry and molecular biology.

Structure and Biosynthesis

PAPS is characterized by its unique structure, consisting of an adenosine molecule linked to a sulfate group via a phosphoanhydride bond. The biosynthesis of PAPS is a two-step process. Initially, adenosine triphosphate (ATP) and sulfate combine in a reaction catalyzed by ATP sulfurylase to produce adenosine 5'-phosphosulfate (APS) and pyrophosphate. Subsequently, APS is phosphorylated by APS kinase to generate PAPS. This pathway is critical for the activation of sulfate for subsequent transfer reactions.

Function

The primary function of PAPS is to serve as a sulfate group donor in sulfation reactions, which are catalyzed by a family of enzymes known as sulfotransferases. These reactions are vital for the modification of various biomolecules, including proteins, lipids, and carbohydrates, enhancing their functional diversity and specificity. Sulfation plays a significant role in increasing the solubility of molecules, modulating their interaction with other biomolecules, and regulating their biological activity.

Clinical Significance

Alterations in the biosynthesis or utilization of PAPS can lead to various genetic disorders and diseases. For instance, mutations affecting sulfotransferase enzymes can result in impaired sulfation reactions, leading to disorders such as multiple sulfatase deficiency and mucopolysaccharidoses. Furthermore, the regulation of PAPS levels is crucial for the detoxification processes in the liver, where sulfation facilitates the excretion of toxic substances and xenobiotics.

Research Applications

PAPS and its associated enzymes have become important targets in drug discovery and therapeutic interventions. Inhibitors of sulfotransferases are being explored for their potential in treating cancer, as sulfation is involved in the modification of hormones and growth factors that can influence tumor growth and metastasis. Additionally, understanding the role of PAPS in disease mechanisms can lead to the development of novel diagnostic and therapeutic strategies.

See Also

• Sulfotransferase
• Sulfation
• Adenosine triphosphate (ATP)
• Genetic disorders

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian